Clinical Trial Update: A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas [Phase 3]

View source ↗

Summary

Phase 3 trial update on β-elemene as maintenance therapy for newly diagnosed malignant gliomas is ongoing, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Glioblastoma

Drugs mentioned

• Elemene (elemene)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Anaplastic Oligoastrocytoma, Anaplastic Astrocytoma | Phase 3 | Status: UNKNOWN